AI Leadership NKI has developed AI models such as BrainMets AI for brain metastases and an AI tool to evaluate pleural mesothelioma treatment responses, with collaborations including Robovision Healthcare. This signals opportunities to sell AI/ML platforms, model deployment, data labeling, and cloud-hosted inference services to pharma, biotech, and hospitals seeking translational and imaging analytics.

Integrated Care Data The close integration of research and clinical care enables rapid translation from discovery to patient treatment. This creates demand for interoperable data platforms, imaging and digital pathology, and workflow automation that connect EHR, lab data, and imaging core facilities.

Partnership Momentum Active collaborations with Oncode Institute, Memorial Sloan Kettering and other partners, plus patient groups, position NKI as a preferred site for joint trials and data-sharing initiatives. Sales opportunities include CRO-style software, clinical trial management tools, patient engagement solutions, and sponsored research programs.

Cloud & Security An AWS-based technology stack and emphasis on safe data handling indicate readiness for scalable cloud services. Potential offerings include cloud hosting, data governance and GDPR-compliant data sharing, AI model hosting, and secure collaboration tools for multi-institution research.

Credibility & Growth Leadership and recognition, including the Spinoza Prize and a SITC keynote, enhance credibility for partnerships and pilots with pharma, biotech, and medtech. Use this reputation to propose co-funded research initiatives, pilot deployments, and technology transfer discussions.